|Articles|August 1, 2006

Pharmaceutical Executive

  • Pharmaceutical Executive-08-01-2006
  • Volume 0
  • Issue 0

Time Machine

Think you've been around a long time? When's the last time your company gave a doctor a cigarette lighter with your logo on it? Put any corks in medicine bottles lately? Can you remember the last hero shot of a pharma CEO on the cover of Time? We can. And we have the artifacts to prove it...

Articles in this issue

about 20 years ago

Getting Better

about 20 years ago

States Curb Marketing

about 20 years ago

From the Editor: Take Your Seat

about 20 years ago

Viewpoint: In Your Words

about 20 years ago

Quiz Answers

about 20 years ago

Introduction: Pharm Exec at 25

about 20 years ago

How Far We've Come

Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.